Copyright © 2012 Jaber Emami et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. A. W. G. Alani, Y. Bae, D. A. Rao, and G. S. Kwon, “Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel,” Biomaterials, vol. 31, no. 7, pp. 1765–1772, 2010. View at Publisher · View at Google Scholar · View at Scopus
2. J. H. Kim, Y. S. Kim, S. Kim et al., “Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel,” Journal of Controlled Release, vol. 111, no. 1-2, pp. 228–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
3. A. O. Nornoo, D. W. Osborne, and D. S. L. Chow, “Cremophor-free intravenous microemulsions for paclitaxel. I: formulation, cytotoxicity and hemolysis,” International Journal of Pharmaceutics, vol. 349, no. 1-2, pp. 108–116, 2008. View at Publisher · View at Google Scholar · View at Scopus
4. G. J. Fetterly and R. M. Straubinger, “Pharmacokinetics of paclitaxel-containing liposomes in rats,” AAPS PharmSci, vol. 5, no. 4, pp. 90–100, 2003. View at Publisher · View at Google Scholar · View at Scopus
5. M. J. Hawkins, P. Soon-Shiong, and N. Desai, “Protein nanoparticles as drug carriers in clinical medicine,” Advanced Drug Delivery Reviews, vol. 60, no. 8, pp. 876–885, 2008. View at Publisher · View at Google Scholar · View at Scopus
6. F. Danhier, N. Lecouturier, B. Vroman et al., “Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation,” Journal of Controlled Release, vol. 133, no. 1, pp. 11–17, 2009. View at Publisher · View at Google Scholar · View at Scopus
7. F. Lacoeuille, F. Hindre, F. Moal et al., “In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel,” International Journal of Pharmaceutics, vol. 344, no. 1-2, pp. 143–149, 2007. View at Publisher · View at Google Scholar · View at Scopus
8. U. S. Sharma, S. V. Balasubbamanian, and R. M. Straubinger, “Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins,” Journal of Pharmaceutical Sciences, vol. 84, no. 10, pp. 1223–1230, 1995. View at Publisher · View at Google Scholar · View at Scopus
9. B. Elsadek, R. Graeser, N. Esser et al., “Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study,” European Journal of Cancer, vol. 46, no. 18, pp. 3434–3444, 2010. View at Publisher · View at Google Scholar · View at Scopus
10. X. Zhang, J. K. Jackson, and H. M. Burt, “Development of amphiphilic diblock copolymers as micellar carriers of taxol,” International Journal of Pharmaceutics, vol. 132, no. 1-2, pp. 195–206, 1996. View at Publisher · View at Google Scholar · View at Scopus
11. S. C. Kim, D. W. Kim, Y. H. Shim et al., “In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy,” Journal of Controlled Release, vol. 72, no. 1–3, pp. 191–202, 2001. View at Publisher · View at Google Scholar · View at Scopus
12. T. Hamaguchi, Y. Matsumura, M. Suzuki et al., “NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel,” British Journal of Cancer, vol. 92, no. 7, pp. 1240–1246, 2005. View at Publisher · View at Google Scholar · View at Scopus
13. C. Zhang, P. Qineng, and H. Zhang, “Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system,” Colloids and Surfaces B, vol. 39, no. 1-2, pp. 69–75, 2004. View at Publisher · View at Google Scholar · View at Scopus
14. F. Q. Hu, G. F. Ren, H. Yuan, Y. Z. Du, and S. Zeng, “Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel,” Colloids and Surfaces B, vol. 50, no. 2, pp. 97–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
15. M. Huo, Y. Zhang, J. Zhou, A. Zou, and J. Li, “Formation, microstructure, biodistribution and absence of toxicity of polymeric micelles formed by N-octyl-N,O-carboxymethyl chitosan,” Carbohydrate Polymers, vol. 83, no. 4, pp. 1959–1969, 2011. View at Publisher · View at Google Scholar · View at Scopus
16. R. H. Müller, K. Mäder, and S. Gohla, “Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 161–177, 2000. View at Publisher · View at Google Scholar · View at Scopus
17. R. H. Müller, M. Radtke, and S. A. Wissing, “Nanostructured lipid matrices for improved microencapsulation of drugs,” International Journal of Pharmaceutics, vol. 242, no. 1-2, pp. 121–128, 2002. View at Publisher · View at Google Scholar · View at Scopus
18. K. V. Pinheiro, V. T. M. Hungria, E. S. Ficker, C. J. Valduga, C. H. Mesquita, and R. C. Maranhão, “Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin's and non-Hodgkin's lymphoma and a preliminary study on the toxicity of etoposide associated with LDE,” Cancer Chemotherapy and Pharmacology, vol. 57, no. 5, pp. 624–630, 2006. View at Publisher · View at Google Scholar · View at Scopus
19. R. C. Maranh, S. R. Graziani, and N. Yamaguchi, “Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients,” Cancer Chemotherapy and Pharmacology, vol. 49, pp. 487–498, 2002.
20. C. J. Valduga, D. C. Fernandes, A. C. Lo Prete, C. H. M. Azevedo, D. G. Rodrigues, and R. C. Maranhão, “Use of a cholesterol-rich microemulsion that binds to low-density lipoproteins receptors as vehicle for etoposide,” Journal of Pharmacy and Pharmacology, vol. 55, no. 12, pp. 1615–1622, 2003. View at Publisher · View at Google Scholar · View at Scopus
21. D. G. Rodrigues, D. A. Maria, D. C. Fernandes et al., “Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies,” Cancer Chemotherapy and Pharmacology, vol. 55, no. 6, pp. 565–576, 2005. View at Publisher · View at Google Scholar · View at Scopus
22. N. Nishiyama and K. Kataoka, “Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery,” Pharmacology and Therapeutics, vol. 112, no. 3, pp. 630–648, 2006. View at Publisher · View at Google Scholar · View at Scopus
23. L. Serpe, M. G. Catalano, R. Cavalli et al., “Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 58, no. 3, pp. 673–680, 2004. View at Publisher · View at Google Scholar · View at Scopus
24. X. G. Zhang, J. Miao, Y. Q. Dai, Y. Z. Du, H. Yuan, and F. Q. Hu, “Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells,” International Journal of Pharmaceutics, vol. 361, no. 1-2, pp. 239–244, 2008. View at Publisher · View at Google Scholar · View at Scopus
25. M. K. Lee, S. J. Lim, and C. K. Kim, “Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles,” Biomaterials, vol. 28, no. 12, pp. 2137–2146, 2007. View at Publisher · View at Google Scholar · View at Scopus
26. R. Li, J. S. Eun, and M. K. Lee, “Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration,” Archives of Pharmacal Research, vol. 34, no. 2, pp. 331–337, 2011. View at Publisher · View at Google Scholar · View at Scopus
27. H. Yuan, J. Miao, Y. Z. Du, J. You, F. Q. Hu, and S. Zeng, “Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells,” International Journal of Pharmaceutics, vol. 348, no. 1-2, pp. 137–145, 2008. View at Publisher · View at Google Scholar · View at Scopus
28. D. Liu, Z. Liu, L. Wang, C. Zhang, and N. Zhang, “Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel,” Colloids and Surfaces B, vol. 85, no. 2, pp. 262–269, 2011. View at Publisher · View at Google Scholar · View at Scopus
29. F. Q. Hu, Y. Zhang, Y. Z. Du, and H. Yuan, “Nimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous system,” International Journal of Pharmaceutics, vol. 348, no. 1-2, pp. 146–152, 2008. View at Publisher · View at Google Scholar · View at Scopus
30. F. Q. Hu, S. P. Jiang, Y. Z. Du, H. Yuan, Y. Q. Ye, and S. Zeng, “Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system,” Colloids and Surfaces B, vol. 45, no. 3-4, pp. 167–173, 2005. View at Publisher · View at Google Scholar · View at Scopus
31. R. H. Müller, M. Radtke, and S. A. Wissing, “Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations,” Advanced Drug Delivery Reviews, vol. 54, pp. S131–S155, 2002. View at Publisher · View at Google Scholar · View at Scopus
32. J. Varshosaz, S. Eskandari, and M. Tabbakhian, “Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants,” Carbohydrate Polymer, vol. 88, pp. 1157–1163, 2012.
33. C. Freitas and R. H. Müller, “Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions,” International Journal of Pharmaceutics, vol. 168, no. 2, pp. 221–229, 1998. View at Publisher · View at Google Scholar · View at Scopus
34. S. J. Lim and C. K. Kim, “Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid,” International Journal of Pharmaceutics, vol. 243, no. 1-2, pp. 135–146, 2002. View at Publisher · View at Google Scholar · View at Scopus
35. V. C. F. Mosqueira, P. Legrand, J. L. Morgat et al., “Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density,” Pharmaceutical Research, vol. 18, no. 10, pp. 1411–1419, 2001. View at Publisher · View at Google Scholar · View at Scopus
36. E. B. Souto, S. A. Wissing, C. M. Barbosa, and R. H. Müller, “Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery,” International Journal of Pharmaceutics, vol. 278, no. 1, pp. 71–77, 2004. View at Publisher · View at Google Scholar · View at Scopus
37. A. Saez, M. Guzmán, J. Molpeceres, and M. R. Aberturas, “Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 3, pp. 379–387, 2000. View at Publisher · View at Google Scholar · View at Scopus